Japan company Meiji Seika Pharma Co., Ltd. and Arysta LifeScience Corporation announced the signing of a licensing agreement for a new insecticide, “flupyrimin” (development code: ME5382) for use in rice protection in India.
Japan company Meiji Seika Pharma Co., Ltd. and Arysta LifeScience Corporation announced the signing of a licensing agreement for a new insecticide, “flupyrimin” (development code: ME5382) for use in rice protection in India.
Under this agreement, Meiji will receive an upfront payment as well as developmental milestone. Arysta will obtain the exclusive rights to develop and commercialize flupyrimin. Meiji will supply the active ingredient to Arysta, while Arysta will formulate, promote and sell the products.
Flupyrimin is a new insecticide discovered by Meiji and is under development in Japan (already submitted for registration) and overseas. Flupyrimin is effective against the major insect pests in rice, such as planthoppers and stem borers, including those populations resistant to existing insecticides. Furthermore, flupyrimin is a promising technology due to the low toxicity against honeybees while there are few effective solutions due to growing concerns over the safety to pollinators.
See full article at Agropages
